Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Oncology: Basic, Translational & Therapy: Basic Science

  • You have access
    FDG-PET, CT and MRI for the detection of experimental colorectal liver metastases: An exploratory study
    Gabie de Jong, Thijs Hendriks, Rob Bleichrodt, Martin Gotthardt, Eric Visser, Wim Oyen and Otto Boerman
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 312;
  • You have access
    PET tracer evaluation in the PAC120 human hormone-dependent prostate cancer xenograft rat model
    Damaris Kukuk, Hans Wehrl, Olivier Raguin, Andreas Schmid, Julia Mannheim, Gerald Reischl and Bernd Pichler
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 310;
  • You have access
    Comparative small animal SPECT/CT imaging of twelve 111In-labelled CCK2-receptor targeting peptides
    Jane Sosabowski, Ciara Finucane, Julie Foster, David Ellison, Jerome Burnet, Peter Laverman and Stephen Mather
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 309;
  • You have access
    Pharmacological evaluation of uPAR expression by 68Ga-PET
    Ali Azhdarinia, Sun Kuk Kwon, Bonnie Angermiller, Pradip Ghosh, Nathaniel Wilganowski and Eva Sevick
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 191;
  • You have access
    A novel application of radiolabeled Cu-ATSM as an indicator of intercellular over-reduced states in disorders with mitochondrial dysfunction: Studies with cybrids carrying mitochondrial DNA mutation from MELAS patients
    Yukie Yoshii, Makoto Yoneda, Masamichi Ikawa, Takako Furukawa, Yasushi Kiyono, Tetsuya Mori, Hiroshi Yoshii, Nobuyuki Oyama, Hidehiko Okazawa and Yasuhisa Fujibayashi
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 239;
  • You have access
    Can PET hypoxia tracers predict radioresistance?
    Kazumi Chia, Rowena Paul, Amanda Weeks, Marcel Cleij, Gregory Mullen, David Landau and Philip Blower
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 237;
  • You have access
    Molecular imaging of tumor carbonic anhydrase (CA) with a 99mTc-labeled small molecule inhibitor
    Shawn Hillier, Genliang Lu, Kevin Maresca, John Marquis, Craig Zimmerman, William Eckelman, John Joyal and John Babich
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 243;
  • You have access
    In vivo evaluation of [F-18]-labeled 3,5-bis(2-fluorobenzylidene)-4-piperidone as an imageable antiproliferative agent
    Vibhudutta Awasthi, Pallavi Lagisetty and Kaustuv Sahoo
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 194;
  • You have access
    Assessment of non-specific binding and optimization of the uptake time for 18F-FMISO hypoxia detection: Correlation with pimonidazole
    Takuro Isoda, Igal Madar and Richard Wahl
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 240;
  • You have access
    PET imaging of the EGFR with 89Zr-panitumumab
    Albert Chang, Ravindra DeSilva and Suzanne Lapi
    Journal of Nuclear Medicine May 1, 2011, 52 (supplement 1) 135;

Pages

  • Previous
  • Next
  • 1
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
SNMMI

© 2025 SNMMI

Powered by HighWire